The lumped constant defined as the conversion factor between the net uptake of fluoro-2-deoxy-D-glucose (FDG) and glucose was calculated from global CMRg l c and from positron emission tomography (PET) using FDG as tracer (CMRpDd. Fifteen healthy, normal volunteers (mean age 24 ± 4 years) were studied. Global CBF and CMRg1c were measured with the Kety-Schmidt technique using 1 33 Xe as tracer, and values were corrected for errors from incomplete diffusion equilibrium for inert gas tracer between brain tissue and cere bral venous blood. Measurements of CMRpDG were obtained with PET using the dynamic and single-scan methods and the K I -k 3 model. Measurements with the Kety-Schmidt technique and PET-FDG were performed simultaneously. Global CBF was 47.1 ± 8.0 mL · 100 g-I . min-t, and CMRg l c was 22.8 ± Determination of the regional glucose metabolism us ing positron emission tomography (PET) with I 8 F _ fluoro-deoxy-D-glucose (FDG) as the tracer is one of the most widely used PET methods for quantification of re gional brain function in humans (Sokoloff et aI., 1977, Reivich et aI., 1979, Phelps et aI., 1979. Since FDG and glucose differ with regard to transport across the blood brain barrier and phosphorylation through the initial step in the glycolysis, FDG net uptake (CMR FDG ) must be converted into glucose net uptake or CMR g \c by the lumped constant (LC) (Sokoloff et aI., 1977).
4.1 fl-mol . 100 g-l . min-I. No difference in CMRpDG was found with the two methods (17.8 ± 1.6 and 18.2 ± 1.3 fl-mol . 100 g-I . min-I, dynamic and single scan methods, respec tively). Accordingly, the lumped constant ranged from 0.80 ± 0.16 to 0.82 ± 0.15, with a mean value of 0.81 ± 0.15. The mean ratio between phosphorylation of FDG and glucose (k 3 *lk 3 ) was 0.39 ± 0.25. The discrepancy between the lumped constant determined in this study and previously obtained values can be explained partly by methodologic problems, and we conclude that most of the discrepancy results from previous overestima tion of global CBF. Key Words: Positron emission tomogra phy-18F-Fluro-deoxy-D-glucose-Lumped constant-Brain glucose metabolism.
brain barrier transport and phosphorylation of the two hexoses:
where KI and KI * are unidirectional clearance from blood to brain of glucose and FDG, respectively, k2 and k2* are fractional clearance from brain to blood of glu cose and FDG, respectively, and k 3 and k3 * are fractional phosphorylation coefficients of glucose and FDG by hexokinase through the initial step of glycolysis. The LC can be estimated, provided these parameters are mea sured or if a constant relation between them is assumed (Kuwabara et aI., 1990 , Holden et aI., 1991 . We have previously determined the ratio between unidirectional clearances for FDG and glucose (K 1 * IK 1) in humans and found a mean value of 1.48, irrespective of blood glucose levels (Hasselbalch et aI., 1996) , but the phosphorylation ratio (k3*lk3) has not been determined in humans, and several assumptions must be made to calculate the LC from parameters obtained in a dynamic PET study (Ku wabara et aI., 1990) . Thus, although this approach is tempting because it allows for a pixel-by-pixel determi nation of the LC, it should be further validated by other approaches that are less dependent on the chosen model. The LC can be determined more simply as the con version factor between FDG and glucose brain net up take. The LC has been calculated as the ratio between net extraction fractions of FDG and glucose measured dur ing steady-state arterial concentrations of the two hexo ses in rats (Sokoloff et aI., 1977) and in humans (Reivich et aI., 1985) . Although this approach is simple, it requires highly accurate determination of the arteriovenous dif ferences of FDG and glucose. The LC value of 0.52 determined in man by Reivich and coworkers was, as pointed out by the authors themselves, underestimated because of contamination of FDG with labeled mannose.
So far, this is the only time that the LC has been mea sured in humans, and the aim of this study was twofold: 1) calculation of the LC by a global method, and 2) determination of the phosphorylation coefficient from the CMR FD G and global metabolic rate for glucose (CMR g 1 c) values obtained in the current study together with a previously determined ratio of the transport coef ficient. We chose to calculate the LC as the difference between CMR FDG and the "true" CMR g 1c, measured with the Kety-Schmidt technique and arteriovenous dif ferences for glucose «a -V) g 1 c) (Kety and Schmidt, 1948) . Provided reliable values for CMR g 1 c are obtained with this technique, the value of the LC depends solely on the PET-FDG method employed, and we therefore compared CMR g 1c with CMRFDG estimated by different methods (i.e., dynamic and single-scan methods).
MATERIALS AND METHODS
Fifteen healthy subjects were studied. Infonned consent was obtained after written information. The data presented in this report are derived from two separate studies, each of which were approved by the Central Ethical Committee. Data regard ing glucose consumption during activation (Madsen et aI., 1995) and data concerning the blood-brain barrier transport of FDG and glucose (Hasselbalch et aI., 1996) have been pub lished separately. Eight subjects (mean age 24 ± 4 years, five men, three women) were studied with uncovered and closed eyes, ears unplugged, and with moderate noise level. Seven subjects (25 ± 3 years, three men, four women) were studied with eyes covered, in dim light, and a low noise level. All subjects were carefully informed about procedures, and sham blood samples were taken before the measurements to famil iarize the subjects to the experimental procedures.
Determination of CMRg)c by the Kety-Schmidt technique
Global CBF was measured by the Kety-Schmidt technique (Kety and Schmidt, 1948) in the de saturation mode, using 1 33 Xe as the flow tracer. Cerebral venous blood was sampled from a catheter inserted percutaneously low on the neck into the internal jugular vein. The catheter tip was advanced to the base of the skull, and the correct placement was verified as described elsewhere (Hasselbalch et aI., 1994) . Arterial blood was sampled from a catheter in the radial artery. Both catheters had the same dead space volume (0.75 mL). Measurements of global CBF were performed as previously described in detail (Madsen et aI., 1993) . In brief, the brain was saturated by an intravenous infusion of 1 33 Xe dissolved in saline at a constant rate of approximately 15 MBq . min-1 for 30 minutes. A 1.5-mL dead space volume was drawn simultaneously from both catheters, immediately before 1 mL of blood was drawn into preweighed syringes. Blood samples were obtained at exact times, t = -2, -1,0,0.5, 1,2,3,4,6,8, and 10 minutes, where t = 0 denotes the time when the Xe infusion was terminated and the CBF study was started. Also at time t = 0, the PET FDG study was started, and the global CBF was thus measured during the first 10 minutes of the PET-FDG study. To avoid loss of 1 33 Xe gas by diffusion, the syringes were reweighed immediately after each run and placed in sealed vials for count ing in a well counter (COBRA 5003, Packard Instrument, Downers Grove, IL, U.S.A.). The measured CBF values were corrected for systematic overestimation of flow values caused by incomplete tracer washout at the end of the measuring pe riod (Madsen et aI., 1993) . From time t = 0 to t = 25 minutes, six to eight paired samples of arterial and jugular venous blood were obtained for determinations of (a -v)g!c ' Global meta bolic rate for glucose was calculated according to Fick ' s prin ciple:
Determination of CMRFDG
We used the PC4096+ PET camera (General Electric Medi cal Systems, Milwaukee, WI, U.S.A.), yielding 15 consecutive slices with a slice thickness of 6.7 mm and a spatial resolution in the image plane of 6.7 mm. Slices were placed parallel to the canthomeatal line (which is a line through the lateral canthus of the eye and the external meatus of the ear) with midslice planes from approximately 10 to 103 mm above the canthomeatal line. With this position, only the brain stem and the small top con vexity of the brain are not in the field of view. After placement of the subject in the scanner, a transmission scan used for attenuation correction was perfonned immediately before the activity scan. At time t = 0, 185 to 210 MBq FDG in 10 mL of saline was injected as a bolus over 20 seconds through an antecubital catheter followed by 5 to 10 mL of saline at the same infusion rate. One-milliliter blood samples were drawn simultaneously from the jugular vein and the radial artery at lO-second intervals from t = 0 to t = 3 minutes, at 20-second intervals from 3 to 5 minutes, at I-minute intervals from 5 to 10 minutes, at 2-minute intervals from 10 to 20 minutes, and at 5-minute intervals for the rest of the scanning period. Dynamic scanning was started at t = 0 with the following scan sequence: 10 6-second scans (0 to 1 minutes), 3 20-second scans (1 to 2 minutes), 8 I-minute scans (2 to 10 minutes), 5 2-minute scans (10 to 20 minutes), 5 5-minute scans (20 to 45 minutes) in eight subjects, and 8 5-minute scans (20 to 60 minutes) in seven subjects. Cross-calibration between scanner and gamma counter was performed every week, and mean values for the period were used. The coefficient of variation of cross calibration factors in the total period of PET -scanning was less than 4%. Global CMRg l c was calculated from PET by two different methods: 1) dynamic method, and 2) single-scan method (autoradiographic method).
Dynamic method. Rate constants were calculated from 15 regions of interest (ROI), with each ROI containing a whole slice, and mean global values were obtained by weighting the 15 ROI with their area. Whole-slice ROI were defined by the 25% of maximal image activity threshold, and ROI were hand drawn accordingly. Correction for CSF space was perfonned by subtracting 2.5% from this area. This value was chosen because the total CSF volume (subarachnoid space plus ven tricles) constitutes 2.5% of the total intracranial volume in a comparable section of the brain in young adults (Schwartz et aI., 1985) . Rate constants were estimated by a nonlinear least square fitting procedure of brain and plasma time activity curves. k4* (dephosphorylation of FDG-6-phosphate) was con sidered negligible during the scanning period and therefore not included in the model. Tracer activity in brain vasculature was subtracted after plasma volume in the brain had been fitted as an additional parameter. The value for CMRpDG was calculated from (C/LC) (Kj* k 3 *)/(k2* + k 3 *) ' where Cp is plasma glu cose concentration, LC is the LC set to I, and K l *, k2 *, and k 3 * are the fitted rate constants of the deoxyglucose model (Huang et aI., 1980) . Single-scan method (autoradiographic method). The CMRpDG was calculated by the single-scan method, as de scribed by Sokoloff et al. (1977) and by Reivich et al. (1979) .
The last 5-minute scan in the dynamic sequence was used for calculation, that is, in eight subjects the final scans were ob tained from 40 to 45 minutes after injection, and in seven subjects from 55 to 60 minutes. Whole-slice ROI (defined as described for the dynamic method) were used. The correction for nonmetabolized FDG in brain and for lag in equilibration of the tissue precursor pool behind the plasma (Sokoloff et aI., 1977) were calculated using the rate constants obtained from the same whole-slice ROI as described earlier. Activity in the last scan used for the single-scan method was corrected for remaining tracer activity in the brain vasculature, assuming a mean cerebral blood volume of 3%.
Finally, we compared the dynamic whole-slice approach to a determination of rate constants in gray and white matter (six regions each at midlevel of brain). Mean gray and white matter rate constants were determined from weighted averages in these ROI as described earlier, and, subsequently, global rate constants and global CMRpDG were calculated assuming a 60:40 ratio between gray and white matter.
Calculation of the phosphorylation coefficient
The phosphorylation coefficient was determined from where K, *, k2 *, and k 3 * are the fitted rate constants of the deoxyglucose model, and K* is the net clearance of FDG equal to (K 1 * k 3 *)/(k2 * + k 3 *) (Kuwabara et aI., 1990), and
which combined yields k 3 */k 3 = (CMRpDG/CMRg]c -(Kj*/K]) . K*/Kj*)/(l-K*/K]*)
Values for CMRpDG, K*, and Kl * were determined from the different PET-FDG methods described earlier, and (K 1 */Kj) was set to 1.48 (Hasselbalch et aI., 1996) .
Blood sample analysis
Blood samples for determination of plasma glucose concen trations were drawn into vials containing fluoride-ethylene diamine tetraacetic acid, stored on ice for 5 minutes, centri fuged, and analyzed in duplicate within 15 minutes on a Beck man Glucose Analyzer (Beckman Instruments, Fullerton, CA, U.S.A.). The FDG blood samples were immediately placed on ice and centrifuged, and 500 ILL of plasma was taken for gamma counting (COBRA 5003, Packard Instrument, Downers Grove, IL, U.S.A.). The blood samples used in the PET-FDG and CBF measurements contained gamma activity from both 1 33 Xe (decay T2 = 5.25 days) and 18F_FDG (decay T2 = 110 minutes). Energy windows were set around the energy peak of each tracer (1 33 Xe = 70 to 90 keV, 18F = 461 to 561 keV), Vol. 18, No.2, 1998 and spillover correction was applied. By extending the time interval from blood sampling to gamma counting of the blood samples, downspill from the 18F window to the 1 33 Xe window decreased rapidly. The blood samples were counted continu ously for the following 12 hours, and the optimal counting time was found to be 8 to 10 hours after injection, where the cross talk correction from FDG into the 1 33 Xe-window was small and no detectable diffusion of 1 33 Xe from the vials had occurred. Cerebral (a -V)g1c was calculated from glucose concentrations in arterial and venous plasma corrected to corresponding whole blood values, as described previously (Madsen et aI., 1995) .
RESULTS
In the 15 subjects studied, plasma glucose was 5.26 ± 0.61 mmollL (mean ± SD). Global CBF was 47.1 ± 8.0 mL· 100 g-l . min-I , (a -V) g 1c was 0.49 ± 0.06 mmol/L, and the resulting global CMR g lc was 22.8 ± 4.1 J..L mol . 100 g-l . min-I .
The FDG rate constants obtained with PET from whole-slice ROI are listed in Table 1 together with the resulting global net clearance (K*) and CMRpDG• The CMRpDG calculated from gray and white matter differed significantly from CMRpDG calculated from whole-slice ROI (16.5 ± 1.4 versus 17.8 ± 1.6, P < 0.0001).
The LC calculated as the ratio between CMRpDG and CMR g 1c ranged from 0.81 to 0.82, depending on the ap plied PET method ( Table 2) . Since there was no signifi cant difference between the two PET methods used, mean values also are listed. The mean phosphorylation ratio calculated from equation 4 was 0.39 ± 0.25 (Table  2) . It was thus possible to calculate LC from equation 2 using constant values for K 1 * IK I (1.48, Hasselbalch et aI., 1996) and k3*lk 3 (0.39, the current study), and obtain an average value for CMR g lc almost identical to that obtained from Fick's principle (22.8 ± 4.1 versus 22.4 ± 1.5) ( Table 2 ). The CMR g 1c calculated by this method differs substantially from CMR g 1c calculated by using a fixed LC value of 0.52 (Reivich et aI., 1985) (22.4 ± 1.5 versus 35.0 ± 2.5, P < 0.00001) .
DISCUSSION

Methodologic considerations
Determination of the LC from measurements of CMR g 1c performed simultaneously with the Kety-Schmidt technique and the PET-FDG technique is a straightfor ward procedure. The two methods do, however, differ with respect to the following: (1) the period of measure ment, and (2) brain regions included in the global aver age measure for CMR g 1c are not necessarily completely identical with the two methodologies. CMRpDG, 18F-fluro-deoxy-D-glucose net uptake; PET-FDG, positron emission tomography with FDG as a tracer. Values are mean ± SD. K, *: unidirectional clearance from blood to brain; k2 *: fractional clearance from brain to blood; k3 *: fractional phosphorylation rate of FDG to FDG-6-P; Vp: plasma volume in brain; K*: net clearance of FDG from blood to brain equal to (K I * k3*)/(k2* + k3*)' CMRFDG, dynamic: (plasma glucose· K*)ILC, where LC:1. CMRpDG, single scan: CMRpDG calculated from the autoradiographic equation as described in methods.
Global whole slice: global rate constants calculated from whole slices as described in methods. Methods) . Single scan (autoradiographic) = CMRFDG calculated from last scan of dynamic sequence using the autoradiographic method and whole slice ROL k*ik3: phosphorylation ratio between FDG and glucose calculated from equation (4). No significant differences were found between the two methods and therefore pooled mean values of dynamic and single scan methods are also shown. Fixed LC: CMR g lc calculated from CMRpDG (single scan method) using a fixed LC value of 0.52 (Reivich et aI., 1985) .
Fixed ratios: LC and CMR g lc calculated from single scan CMRpDG using fixed ratios in equation (2);
Kl*/K I = 1.48 (Hasselbalch et aI., 1996) ; k*ik3 = 0.39 (mean value determined in' present study).
t p < 0.0001 compared to CMR g lc calculated in the present study (22.4 ± 1.5).
was calculated from two Kety-Schmidt experiments, one with high and one with low flow (59.5 and 37.1 mL, respectively). A contamination of 10%, 25%, and 50% blood from the previous sample resulted in an underes timation of CBF of 2%, 5%, and 10%, respectively, in both the high and low CBF example. It is unlikely that this contamination of 133 Xe from the previous sample should lead to an underestimation of CBF by more than a small percentage because several blood samples for arteriovenous differences for FDG, glucose, lactate, and oxygen were obtained between each 133 Xe sample, in creasing the flushing volume to five to six times the dead space volume. We conclude that this possible error ex plains only a small part of the discrepancy between our CBF values and those previously reported (Scheinberg and Stead, 1949; Novack et aI., 1953; Gottstein et aI., 1963; Cohen et aI., 1967; Takeshita et aI., 1974) .
The PET scanner used in the current study had an axial field of view of 10 cm, and only a small part of the brain was outside the field of view. Assuming that mean CMR P DG was the same outside as inside the field of view, the measured value is representative of the global value.
Almost identical values for CMRpDG were obtained with the whole-slice approach, regardless of the method used (dynamic or single scan). When global rate con stants were determined from gray and white matter, a significant underestimation of CMRpDG was found (Table 1) . This underestimation is most likely caused by inclusion of white matter in the gray matter ROI because of the limited spatial resolution of the PET-scanner. The single-scan method is not affected to the same degree by errors in rate constants (Sokoloff et aI., 1977) . Therefore the single-scan method may be more robust (coefficient of variation 7% compared with 9% for the dynamic methods), and for further analysis, we only looked at the single-scan method and the dynamic whole-slice method, which yielded almost identical results.
Absolute values for CMRFDG and CMRglc
The LC value obtained in the current study from si multaneous measurements of CMRpDG and CMR gI c was higher than the previously calculated values of 0.42 to 0.60 (Phelps et aI., 1979 , Reivich et aI., 1985 , Brooks et aI., 1987 Kuwabara et aI., 1990) . has been used a standard global value for CMR g lc, either
for direct calculation of LC (Phelps et aI., 1979; Brooks et aI., 1987; Kuwabara et aI., 1990) or for validation of obtained values for LC (Reivich et aI., 1985) . and subsequently multiplied with cerebral arteriovenous differences for glucose (Scheinberg and Stead, 1949; No vack et aI., 1953; Gottstein et aI., 1963; Cohen et aI., 1967; Takeshita et aI., 1974) . However, despite the solid theoretical foundation of the Kety-Schmidt technique, the mean global CBF value of 53 mL . 100 g-l . min-1 derived from these studies probably represents an over estimation of the true global CBF value (Lassen, 1959; Madsen et aI., 1993) . In the application of the Kety Schmidt technique, diffusion equilibrium for inert gas tracer between the brain and cerebral venous blood is not reached. Only one of the five studies corrected for this nonequilibrium (Cohen et aI., 1967) , and as a conse quence, the global values for CBF and CMR g lc in the remaining four studies lead to an overestimation of the mean global value derived from these five studies (Scheinberg and Stead, 1949; Novack et a!., 1953; Gottstein et a!., 1963; Cohen et aI., 1967; Takeshita et aI., 1974) . Several approaches to correct for this systematic overestimation have been developed (Lassen and Lane, 1961; Madsen et aI., 1993) . When values obtained with the Kety-Schmidt technique are corrected for errors caused by incomplete tracer equilibrium, CBF and CMR g lc are 45 mL . 100 g-l . min-1 and 25 f1mol . 100 g-l .
min -I , respectively (Lassen and Lane, 1961; Cohen et aI., 1967; Madsen et aI., 1993) . The CMR g lc value that
was obtained in the current study was close to the CMR g1 c values obtained in these studies. It is also similar to the CMR g 1c value obtained with ll C-labeled glucose by Blomqvist and others (1990) . In conclusion, in calcula tions of the LC (Phelps et aI., 1979; Brooks et aI., 1987; Kuwabara et aI., 1990) , the applied value for CMR g 1c has probably been higher than the true CMR g 1c value, and consequently, the LC value would be underestimated, and this may account for most of the difference between the LC value in the current study and previously calcu lated LC values of 0.42 to 0.60 (Phelps et aI., 1979; Brooks et aI., 1987; Kuwabara et aI., 1990 ).
In only one study, direct measurement of the LC has been attempted (Reivich et aI., 1985) . Reivich Other methodologic problems may explain the discrep ancy, and further studies are needed to clarify this issue.
However, both studies (Reivich et aI., 1985 ; the current study) indicate that the LC is higher than 0.52. This is consistent with the observation by Frackowiak and oth ers (1988), who calculated the LC from cerebral oxygen metabolism by assuming a molar ratio between oxygen and glucose metabolism of 5.6 (Lassen, 1959) , and ar rived at a LC value of 0.75. Crane and coworkers (1983) measured the FDG LC by the brain uptake index method in the pentobarbital-anesthetized rat and compared the observed value with a value predicted from measured kinetics of transport and metabolism of FDG and glu cose. Although pentobarbital anesthesia affects the ab solute values for transport and phosphorylation of FDG and glucose, it is unlikely that the transport and phos phorylation ratios are affected. The transport coefficient obtained by Crane and colleagues (FGD/glucose = 1.67 ± 0.07) was similar to that obtained in non sedated healthy volunteers (1.48 ± 0.22, Hasselbalch et aI., 1996) , which speaks against a significant effect of pen tobarbital on the transport ratio. The observed and pre dicted FDG LC values in the study of Crane and cowork ers (1983) were 0.77 and 0.85, and thus in the same order of magnitude as the value obtained in the current study.
In conclusion, the discrepancy between the LC deter mined in this study and previously obtained values can be partly explained by methodologic problems, and it is concluded that most of the discrepancy results from pre-vious overestimation of global CBF, and subsequently, global CMR g! c.
Kuwabara and associates (1990) and Holden and oth ers (1991) have proposed that the LC can be determined regionally from dynamic PET data, assuming that the FDG/glucose blood-brain barrier transport ratio (KJ */ KJ) as well as the phosphorylation ratio (k3 *lk3) are known and constant. In our study, we found a mean k3*lk3 ratio of 0.39. Although the SD was relatively large, the value is in the same order of magnitude as the previously reported value in rat brain of 0.55 (Crane et aI., 1983) . Equation 2, with fixed ratios of 1.48 (Hassel balch et aI., 1996) and 0.39 for KJ*/KJ and k3*lk3' re spectively, may generate reliable CMR g lc values from PET-FDG as shown in the current study, but the exact value of the phosphorylation coefficient should be cor roborated by future experiments, thus further validating the kinetic approach. Also notice that the method applies only to normal brain tissue because the phosphorylation coefficient has been shown to vary considerably between normal and pathologic brain tissue (Kapoor et aI., 1989) .
